|
NMRA Neumora Therapeutics Inc 1885522 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-53,458,000.00 |
| Balance Sheet |
|
Current Assets
|
$153,434,000.00 |
|
Assets
|
$153,877,000.00 |
|
Current Liabilities
|
$30,115,000.00 |
|
Liabilities
|
$83,197,000.00 |
|
Equity
|
$70,680,000.00 |
|
Shares Out
|
174260000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-46,404,000.00 |
|
Investing Cash Flow
|
$71,000.00 |
| Market Analysis |
Market Cap
|
$287,529,000.00 |
|
Price
|
$1.67 |
|
BVPS
|
0.41 |
|
PB
|
4.02 |
|
EPS
|
-0.30 |
|
FCF
|
$-46,420,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.35 |
|
|
2026-05-07 |
-0.30 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.33 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.35 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NMRA documents filed with the SEC.
NMRA Filings
Clear
